Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

QT Interval Abnormalities in Sulfonylurea Treated Type 2 Diabetes: Relationship to Treatment Induced Hypoglycaemia and Glycaemic Variability Determined by Simultaneous Ambulatory Monitoring

NCT02298803 is registered in ClinicalTrials.gov with Royal Prince Alfred Hospital, Sydney, Australia as lead sponsor.

NCT NCT02298803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02298803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
QT Interval Abnormalities in Sulfonylurea Treated Type 2 Diabetes: Relationship to Treatment Induced Hypoglycaemia and Glycaemic Variability Determined by Simultaneous Ambulatory Monitoring
Lead sponsor
Royal Prince Alfred Hospital, Sydney, Australia
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2015
Completion date
January 31, 2016
Enrollment
30 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes related complications